These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 21956411)

  • 1. Clinical review: Ethical and medical considerations of androgen deprivation treatment of sex offenders.
    Gooren LJ
    J Clin Endocrinol Metab; 2011 Dec; 96(12):3628-37. PubMed ID: 21956411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of Paraphilic Disorders in Sexual Offenders or Men With a Risk of Sexual Offending With Luteinizing Hormone-Releasing Hormone Agonists: An Updated Systematic Review.
    Turner D; Briken P
    J Sex Med; 2018 Jan; 15(1):77-93. PubMed ID: 29289377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Legal and ethical issues in the use of antiandrogens in treating sex offenders.
    Melella JT; Travin S; Cullen K
    Bull Am Acad Psychiatry Law; 1989; 17(3):223-32. PubMed ID: 2529005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The treatment of sex offenders: evidence, ethics, and human rights.
    Birgden A; Cucolo H
    Sex Abuse; 2011 Sep; 23(3):295-313. PubMed ID: 20937793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk/benefit ratio of androgen deprivation treatment for sex offenders.
    Berlin FS
    J Am Acad Psychiatry Law; 2009; 37(1):59-62. PubMed ID: 19297635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Assessment of a new law for sex offenders implemented in France in 1998].
    Tesson J; Cordier B; Thibaut F
    Encephale; 2012 Apr; 38(2):133-40. PubMed ID: 22516271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Learning from research: Adapting interventions for sexual offending to improve outcomes.
    Völlm B; Craissati J; Grubin D; Skett S; Williams F
    Crim Behav Ment Health; 2019 Aug; 29(4):227-238. PubMed ID: 31478289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential side effects of androgen deprivation treatment in sex offenders.
    Giltay EJ; Gooren LJ
    J Am Acad Psychiatry Law; 2009; 37(1):53-8. PubMed ID: 19297634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double-blind, controlled, clinical trial planned in germany to investigate the efficacy of psychotherapy combined with triptorelin in adult male patients with severe pedophilic disorders: presentation of the study protocol.
    Briken P; Berner W;
    Isr J Psychiatry Relat Sci; 2012; 49(4):306-13. PubMed ID: 23585468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy, safety and ethics of the use of testosterone-suppressing agents in the management of sex offending.
    Khan O; Mashru A
    Curr Opin Endocrinol Diabetes Obes; 2016 Jun; 23(3):271-8. PubMed ID: 27032060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug treatment of paraphilic and nonparaphilic sexual disorders.
    Guay DR
    Clin Ther; 2009 Jan; 31(1):1-31. PubMed ID: 19243704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiandrogen treatment of male sex offenders.
    Waltz G; Risen C; Levine SB
    Health Matrix; 1987; 5(1):51-5. PubMed ID: 10282259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "But I didn't do it!": ethical treatment of sex offenders in denial.
    Levenson JS
    Sex Abuse; 2011 Sep; 23(3):346-64. PubMed ID: 20937795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacotherapy of sexual offenders.
    Richer M; Crismon ML
    Ann Pharmacother; 1993 Mar; 27(3):316-20. PubMed ID: 8453171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteoporosis in men treated with androgen deprivation therapy for prostate cancer.
    Ross RW; Small EJ
    J Urol; 2002 May; 167(5):1952-6. PubMed ID: 11956415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Medical prevention of recidivism by sexual delinquents].
    Milgrom E; Bouchard P; Olié JP
    Bull Acad Natl Med; 2010 Jun; 194(6):1033-44. PubMed ID: 21513136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Androgen deprivation therapy: evidence-based management of side effects.
    Ahmadi H; Daneshmand S
    BJU Int; 2013 Apr; 111(4):543-8. PubMed ID: 23351025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemical castration for sex offenders.
    Grubin D; Beech A
    BMJ; 2010 Jan; 340():c74. PubMed ID: 20068060
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacologic treatment of sex offenders with paraphilic disorder.
    Garcia FD; Delavenne HG; Assumpção Ade F; Thibaut F
    Curr Psychiatry Rep; 2013 May; 15(5):356. PubMed ID: 23572328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endocrine treatment of prostate cancer.
    Tammela T
    J Steroid Biochem Mol Biol; 2004 Nov; 92(4):287-95. PubMed ID: 15663992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.